Cytokine responses to two common respiratory pathogens in children are dependent on interleukin-1β

Alice C-H Chen1,2, Yang Xi1,2, Melanie Carroll1

  • 1Diamantina Institute, The University of Queensland, Brisbane, Australia.

ERJ Open Research
|December 6, 2017
PubMed

Insights

Interleukin-1 beta (IL-1β) significantly influences immune responses in children with protracted bacterial bronchitis (PBB) and bronchiectasis. Blocking IL-1β may reduce airway inflammation but could compromise immunity against common respiratory pathogens.

Area of Science:

  • Immunology
  • Pediatric Respiratory Medicine
  • Infectious Diseases

Background:

  • Protracted bacterial bronchitis (PBB) and bronchiectasis share neutrophilic airway inflammation and an interleukin-1 beta (IL-1β) signature.
  • The role of the IL-1β pathway in host defense against respiratory pathogens in children is not fully understood.

Purpose of the Study:

  • To compare systemic immune responses to common pathogens in children with PBB, bronchiectasis, and healthy controls.
  • To investigate the importance of the IL-1β pathway in these immune responses.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from children with PBB, bronchiectasis, and controls were stimulated with non-typeable Haemophilus influenzae (NTHi).
  • The effect of an IL-1 receptor antagonist (IL-1Ra) on cytokine production was assessed in NTHi- and rhinovirus-stimulated PBMCs.
  • Cellular responses were analyzed across various immune cell types, including T cells and NK cells.

Main Results:

  • NTHi stimulation induced high levels of IL-1β, IL-6, interferon-gamma (IFN-γ), and IL-10 in PBMCs from all groups.
  • Blocking IL-1β with IL-1Ra inhibited cytokine synthesis in response to NTHi and rhinovirus.
  • IL-1Ra significantly reduced IFN-γ production by T cells and NK cells.

Conclusions:

  • IL-1β plays a crucial role in regulating cellular immune responses to NTHi and rhinovirus in children.
  • While targeting the IL-1β pathway may reduce airway inflammation, it could potentially impair protective immunity against these pathogens.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.1K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K